TN2013000396A1 - Formulations comprising 2 -amino- 2- [2- (4 - octylphenyl) ethyl] propane -1, 3 - diol - Google Patents
Formulations comprising 2 -amino- 2- [2- (4 - octylphenyl) ethyl] propane -1, 3 - diolInfo
- Publication number
- TN2013000396A1 TN2013000396A1 TNP2013000396A TN2013000396A TN2013000396A1 TN 2013000396 A1 TN2013000396 A1 TN 2013000396A1 TN P2013000396 A TNP2013000396 A TN P2013000396A TN 2013000396 A TN2013000396 A TN 2013000396A TN 2013000396 A1 TN2013000396 A1 TN 2013000396A1
- Authority
- TN
- Tunisia
- Prior art keywords
- octylphenyl
- diol
- propane
- formulations
- ethyl
- Prior art date
Links
- KKGQTZUTZRNORY-UHFFFAOYSA-N fingolimod Chemical compound CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1 KKGQTZUTZRNORY-UHFFFAOYSA-N 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229920000858 Cyclodextrin Polymers 0.000 abstract 1
- 102000011011 Sphingosine 1-phosphate receptors Human genes 0.000 abstract 1
- 108050001083 Sphingosine 1-phosphate receptors Proteins 0.000 abstract 1
- 239000000945 filler Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229940075993 receptor modulator Drugs 0.000 abstract 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
A solid pharmaceutical composition suitable for oral administration, comprising: (a) a S1P receptor modulator; (b) a filler, and (c) a cyclodextrin.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161545835P | 2011-10-11 | 2011-10-11 | |
| PCT/US2012/031340 WO2012135561A1 (en) | 2011-04-01 | 2012-03-30 | Formulations comprising 2 -amino- 2- [2- (4 - octylphenyl) ethyl] propane -1, 3 - diol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TN2013000396A1 true TN2013000396A1 (en) | 2015-01-20 |
Family
ID=54337518
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2013000396A TN2013000396A1 (en) | 2011-10-11 | 2013-09-30 | Formulations comprising 2 -amino- 2- [2- (4 - octylphenyl) ethyl] propane -1, 3 - diol |
Country Status (1)
| Country | Link |
|---|---|
| TN (1) | TN2013000396A1 (en) |
-
2013
- 2013-09-30 TN TNP2013000396A patent/TN2013000396A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JO3177B1 (en) | Formulations comprising 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol | |
| CY1123434T1 (en) | lyophilized drug nanosuspensions | |
| PH12017501495A1 (en) | Dosage regimen of an s1p receptor modulator | |
| IL228709A0 (en) | Unit dose form for oral administration | |
| PH12013502325A1 (en) | Drug delivery system | |
| UY34080A (en) | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION THAT INCLUDES FEXOFENADINE AND PREPARATION METHODS | |
| TN2013000396A1 (en) | Formulations comprising 2 -amino- 2- [2- (4 - octylphenyl) ethyl] propane -1, 3 - diol | |
| PL2714042T3 (en) | An analgesic pharmaceutical composition for oral administration | |
| AR124661A2 (en) | FORMULATIONS | |
| EA201992463A1 (en) | DRUG DELIVERY SYSTEM | |
| CR8977A (en) | HIGH DOSES OF IBANDRONATE FORMULATIONS |